Jiangsu Hengrui Medicine will invest $240 million to build an internationally compliant biopharmaceutical production facility in its home city of Lianyungang, Jiangsu Province. The company has acquired a 200 acre site in the Lianyungang Technological Development Zone for the plant. Two months ago, Hengrui announced plans to spend $137 million building a new biologic drug manufacturing facility in Suzhou.
Help employers find you! Check out all the jobs and post your resume.
